What is Veracyte's debt-to-equity?

Veracyte (VCYT) reported debt-to-equity of 0× in Q1 2026.

How has Veracyte's debt-to-equity changed year-over-year?

Veracyte's debt-to-equity decreased by 30.7% year-over-year, from 0× to 0×.

What is the long-term trend for Veracyte's debt-to-equity?

Over 5 years (2020 to 2025), Veracyte's debt-to-equity has grown at a 0.7% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

Veracyte VCYT Debt-to-equity

Debt-to-equity at other companies

Guardant HealthGH

3×—

Natera, Inc.NTRA

0.1×0.0×

Bio-Rad LaboratoriesBIO

0.1×-0.1×

RevvityRVTY

0.5×+0.1×

Labcorp HoldingsLH

0.8×0.0×

Quest DiagnosticsDGX

0.9×-0.1×

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.28B+10.7%

Enterprise value$4.05B+7.4%

P/E48.6×-68.3×

P/S7.9×-0.4×

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Current ratio9.3×+4.2×

Where this comes from

Calculated from Veracyte’s reported figures.

total debt/total stockholders equity=0×

Based on the most recent quarter.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's debt-to-equity?: Veracyte (VCYT) reported debt-to-equity of 0× in Q1 2026.
How has Veracyte's debt-to-equity changed year-over-year?: Veracyte's debt-to-equity decreased by 30.7% year-over-year, from 0× to 0×.
What is the long-term trend for Veracyte's debt-to-equity?: Over 5 years (2020 to 2025), Veracyte's debt-to-equity has grown at a 0.7% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.